Wuhan Keqian Biology Co.,Ltd (SHA:688526)

SHA:688526 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	276.97	543.48	581.74	456.07	555.36	1,914
Short-Term Investments	521.69	671.76	451.14	810	547.35	-
Trading Asset Securities	922.8	719.51	745.04	674.83	212.95	270
Cash & Short-Term Investments	1,721	1,935	1,778	1,941	1,316	2,184
Cash Growth	61.52%	8.82%	-8.40%	47.52%	-39.76%	225.46%
Accounts Receivable	322.71	354.81	343.15	406.52	294.4	184.9
Other Receivables	4.55	55.06	37.47	34.96	32.02	2.22
Receivables	327.26	409.88	635.68	441.48	326.42	187.12
Inventory	135.65	125.6	144.8	169.4	108.82	71.07
Other Current Assets	438.69	2.86	7.69	9.12	10.42	19.45
Total Current Assets	2,623	2,473	2,566	2,561	1,761	2,462
Property, Plant & Equipment	906.67	887.05	858.9	905.38	904.15	557.83
Long-Term Investments	67.37	1,029	1,136	799.2	940.15	0.1
Goodwill	-	-	3.31	3.31	-	-
Other Intangible Assets	65.47	65.1	60.03	59.91	57.24	53.42
Long-Term Deferred Tax Assets	0.59	0.96	0.3	26.8	16.28	11.46
Long-Term Deferred Charges	1.24	1.6	1.18	-	-	-
Other Long-Term Assets	1,089	38.95	45.88	35.13	46.2	26.51
Total Assets	4,753	4,496	4,671	4,391	3,725	3,111
Accounts Payable	131.13	178.26	165.03	244.27	215.74	145.49
Accrued Expenses	44.06	87.64	88.36	92.79	76.04	50.6
Short-Term Debt	-	-	206.65	131.6	18.03	60.06
Current Portion of Long-Term Debt	-	-	80.05	-	60.06	-
Current Portion of Leases	1.46	1.35	1.06	0.65	-	-
Current Income Taxes Payable	43.77	30.77	53.98	31.09	46.83	22.91
Current Unearned Revenue	213.7	148.6	157.61	101.7	63.18	63.97
Other Current Liabilities	60.99	16.87	5.51	21.74	12.35	11.16
Total Current Liabilities	495.11	463.5	758.25	623.84	492.24	354.18
Long-Term Debt	-	-	-	140.11	-	-
Long-Term Leases	5.48	5.55	5.75	7.12	-	-
Long-Term Unearned Revenue	61.01	66.04	56.62	61.72	47.5	36.72
Long-Term Deferred Tax Liabilities	18.61	17.71	12.97	56.84	29.68	8.69
Other Long-Term Liabilities	-	-	-	1.99	1.99	2.81
Total Liabilities	580.21	552.8	833.59	891.63	571.41	402.4
Common Stock	466.13	466.13	466.17	466.21	465.13	465
Additional Paid-In Capital	1,128	1,140	1,141	1,135	1,115	1,104
Retained Earnings	2,565	2,387	2,204	1,897	1,576	1,140
Treasury Stock	-17.69	-34.77	-0.57	-1.12	-1.86	-
Comprehensive Income & Other	30.53	-17.14	25.33	-	-	-
Total Common Equity	4,172	3,941	3,836	3,497	3,153	2,709
Minority Interest	0.87	2.05	2.03	2.07	0.44	-
Shareholders' Equity	4,173	3,943	3,838	3,499	3,154	2,709
Total Liabilities & Equity	4,753	4,496	4,671	4,391	3,725	3,111
Total Debt	6.94	6.9	293.51	279.48	78.09	60.06
Net Cash (Debt)	1,715	1,928	1,484	1,661	1,238	2,124
Net Cash Growth	71.10%	29.87%	-10.65%	34.25%	-41.73%	216.51%
Net Cash Per Share	3.65	4.13	3.19	3.57	2.67	5.50
Filing Date Shares Outstanding	471.74	463.92	464.69	466.21	465.13	465
Total Common Shares Outstanding	471.74	463.92	466.17	466.21	465.13	465
Working Capital	2,128	2,010	1,808	1,937	1,269	2,107
Book Value Per Share	8.84	8.49	8.23	7.50	6.78	5.82
Tangible Book Value	4,106	3,876	3,772	3,434	3,096	2,655
Tangible Book Value Per Share	8.71	8.35	8.09	7.37	6.66	5.71
Buildings	-	291.93	277.02	270.37	237.39	137.25
Machinery	-	974.9	954.6	942.59	511.38	243.79
Construction In Progress	-	134.51	43.05	17	388.72	354.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.